Table 1 Simulation result using deterministic input variables (simulation horizon of 5 years)
Treatment scenario | Cumulated total direct costs base case [in EUR] | Cumulated effectiveness base case [in QALY] | Incremental net monetary benefit (INMB), comparator: Treatment 1 [in EUR] | Incremental cost effectiveness ratio (ICER), comparator: Treatment 1 [EUR/QALY] | Ranking treatment scenarios | ||
|---|---|---|---|---|---|---|---|
Per patient | Per cohort | Per patient | Per cohort | ||||
Treatment 1: Without DiGA scenario | 7,933 | ~39,482 million | 2.16478 | 10,774,482 | 1 | ||
Treatment 2: With DiGA scenario standard of care | 7,980 | ~39,720 million | 2.16538 | 10,777,473 | -14.84 | 79,466 | 2 |
Treatment 3: With DiGA future scenario | 9,469 | ~47,130 million | 2.18367 | 10,868,511 | -501.43 | 81,335 | 3 |
